Teva Access To Pfizer Docs On Detrol Restricted

Law360, New York (June 4, 2009, 12:00 AM EDT) -- A federal judge has limited Teva Pharmaceuticals USA Inc.'s access to Pfizer Inc. documents in a dispute over the generics maker's attempts to introduce its own version of Pfizer bladder control drug Detrol LA.

Judge Mark Falk of the U.S. District Court for the District of New Jersey on Thursday ruled that Teva cannot access the marketing strategy behind the launch of Pfizer's new bladder drug Toviaz, which Teva claims is designed to replace Detrol in the market.

The generics maker had argued that Pfizer's plans...
To view the full article, register now.